Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Essential Pharma, 7 Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, United Kingdom
Camcolit 400 mg, controlled release Lithium Carbonate.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. White film coated tablet, engraved “CAMCOLIT-S” around one face and having a score line on the reverse. The tablet is a controlled release formulation. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each film-coated tablet contains 400 mg lithium carbonate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Lithium |
Little is known about the way the lithium ion can modify neurotransmission within the CNS. Many of the proposed mechanisms have suggested an inhibitory effect on components of various neurotransmitter signalling pathways, such as cyclic AMP formation, cyclic GMP formation, G-proteins or inositol phosphate metabolism. |
| List of Excipients |
|---|
|
Maize starch |
Polypropylene containers containing 56, 100 or 500 film-coated tablets.
For hospital use only, screw-cap amber glass bottles containing 50 or 100 film-coated tablets.
Not all pack sizes may be marketed.
Essential Pharma, 7 Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, United Kingdom
PL 41871/0003
13 June 1997
| Drug | Countries | |
|---|---|---|
| CAMCOLIT | Hong Kong, Ireland, Malta, Netherlands, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
